3190 results for «988»
3190 results
Challenging cases in difficult clinical scenarios
14 Apr 2021 – From EuroPCR 2021
Thanks to this session, you will know more about how to manage simultaneous myocardial infarction and arm ischemia, how to facilitate antegrade wiring of tortuous RCA thanks to sub-intimal dissection and stabilisation, how to guide the way when handling a difficult graft PCI, and more!
How to tackle calcified lesions for a good outcome
14 Apr 2021 – From EuroPCR 2021
View this session if you're interested in CHIP PCI in ACS with heart failure and high bleeding risk, calcific left main stem restenosis after prior treatment with lithotripsy, calcific restenosis and tight distal narrowing, and much more!
Nightmares in the cath lab: prevention is better than cure
14 Apr 2021 – From EuroPCR 2021
In this session, watch a case of emergency high-risk PCI following TAVI in bicuspid anatomy, discover an unconventional treatment for re-stenosis, study how to deal with an emergency LM PCI in a young patient with ACS, and much more!
DK crush or Culotte?
14 Apr 2021 – From EuroPCR 2021
Don't miss this session if you wish to discover how OCT guidance, assisted by IVL, can help in case of DK crush, or how high-risk left main PCI in a patient with severe aortic stenosis can be managed, among others...
Primary PCI: surprise, surprise!
14 Apr 2021 – From EuroPCR 2021
Thanks to this session, view an unusual posterior wall infarction, study a "nightmare" acute coronary syndrome case in the EP Lab, consider STEMI with lots of clots, and more!
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
Outcomes in patients with atrial fibrillation randomized to receive LAA closure or oral anticoagulation: Primary results of the CHAMPION-AF clinical trial
28 Mar 2026
During the first Late-Breaking Trial session of the 2026 ACC Congress held in New Orleans, Saibal Kar, principal investigator of the CHAMPION-AF trial, presented the 3-year results of this groundbreaking study, which were simultaneously published in the NEJM (DOI: 10.1056/NEJMoa2517213).
Author
TRILUMINATE pivotal: A landmark randomized clinical trial of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation
04 Mar 2023
Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
Author
The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial
25 Oct 2023
Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...
Author
TRI.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation
31 Aug 2024
Alex Sticchi provides his take on the results of the TRI.FR trial presented by Erwan Donal at the ESC Congress 2024 in London.
Author
